The evolving medicines model
‘The very factors that drive the success of the generic market in the UK may be under threat’
Future of Pharmaceuticals 2019
It takes an average of 10-15 years to get a drug to market, but how will artificial intelligence make a difference in the early development stages of drugs? Our Future of Pharmaceuticals special report, published in The Times, explores how the industry is moving to be part of open, learning communities where collaboration is at the forefront. It examines why pharmaceuticals is lagging behind in exploiting technological possibilities and whether we should redefine ageing as a disease. It looks at antimicrobial resistance and what antibiotics are really worth. Also featured is an infographic analysing the global rise of generic drugs.
In association with
In this report
Sponsored content
-
Drug development goes digital
Strategic use of patient data is signalling a bright future for drug development in the face of unprecedented global healthcare challenges
-
Big data can help rescue healthcare
Innovative use of transformative big data can bring medicines to those in need, improve healthcare systems and empower patients
-
Tackling the next frontier of liver disease
An innovative pharma company has set its sights on treating non-viral liver diseases
-
Q&A: Connecting the dots along the pharma value chain
Industry leaders hold the “magic wand” to empower their talent to supercharge the potential of a patient-centric pharma value chain, says Louis Hendriks, founder and initiator of Global Value Web
-
Acino and Quay steer new course for contract development and manufacturing
As the era of blockbuster drugs comes to an end, pharma is moving towards drugs that are increasingly complex and made for small patient populations, creating opportunities and challenges for contract development and manufacturing organisations (CDMOs)
-
Business Transformation
The past 18 months has forced business transformation on most companies, whether they wanted it or not. Here, we examine whether new business models are here for the long-term, new management structures and the real difference between digital transformation and digitisation.
-
The Future of Marketing and Customer Experience
After a tumultuous 2020 of budget cuts, furlough and redundancies, the marketing industry is looking to rebuild in 2021. From the future of digital advertising without third-party cookies to improving diversity and inclusion and finding new ways to improve lead generation, marketers are facing new challenges.
-
Future of Ecommerce 2021
As the pandemic pushed previously in-store brands online, luxury retail has finally embraced ecommerce, L’Oréal’s new digital boss explains how beauty went touchless and we explore how innovative warehouse tech can offer retail an edge. We also examine the magic of live shopping, the rise of super apps and how to get returns right
-
The Future of Work 2021
As the UK economy slowly reopens, thoughts are increasingly turning to what work will look like post-pandemic. But with many people looking for a career change, issues around proximity bias and the loss of young people from the work force, there are as many opportunities as there are challenges.